174 related articles for article (PubMed ID: 36345437)
1. Molecular docking studies and biological evaluation of isoxazole-carboxamide derivatives as COX inhibitors and antimicrobial agents.
Hawash M; Jaradat N; Abualhasan M; Qaoud MT; Joudeh Y; Jaber Z; Sawalmeh M; Zarour A; Mousa A; Arar M
3 Biotech; 2022 Dec; 12(12):342. PubMed ID: 36345437
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, molecular docking studies and biological evaluation of thiazole carboxamide derivatives as COX inhibitors.
Hawash M; Jaradat N; Abualhasan M; Şüküroğlu MK; Qaoud MT; Kahraman DC; Daraghmeh H; Maslamani L; Sawafta M; Ratrout A; Issa L
BMC Chem; 2023 Mar; 17(1):11. PubMed ID: 36879343
[TBL] [Abstract][Full Text] [Related]
3. New Thiazole Carboxamide Derivatives as COX Inhibitors: Design, Synthesis, Anticancer Screening, In Silico Molecular Docking, and ADME Profile Studies.
Hawash M; Jaradat N; Sabobeh R; Abualhasan M; Qaoud MT
ACS Omega; 2023 Aug; 8(32):29512-29526. PubMed ID: 37599929
[TBL] [Abstract][Full Text] [Related]
4. Synthesis,
Alam W; Khan H; Saeed Jan M; Rashid U; Abusharha A; Daglia M
Front Chem; 2023; 11():1222047. PubMed ID: 37744065
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of tetrazole derivatives as TNF-α, IL-6 and COX-2 inhibitors with antimicrobial activity: Computational analysis, molecular modeling study and region-specific cyclization using 2D NMR tools.
Lamie PF; Azmey AF
Bioorg Chem; 2019 Nov; 92():103301. PubMed ID: 31563696
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of novel 5-benzylidene-3-(3-phenylallylideneamino)imidazolidine-2,4-dione derivatives causing clinical pathogens: Synthesis and molecular docking studies.
Ali D; Alarifi S; Chidambaram SK; Radhakrishnan SK; Akbar I
J Infect Public Health; 2020 Dec; 13(12):1951-1960. PubMed ID: 33289644
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel isoxazole-carboxamide derivatives as promising agents for melanoma and targeted nano-emulgel conjugate for improved cellular permeability.
Hawash M; Jaradat N; Eid AM; Abubaker A; Mufleh O; Al-Hroub Q; Sobuh S
BMC Chem; 2022 Jun; 16(1):47. PubMed ID: 35751124
[TBL] [Abstract][Full Text] [Related]
8. New Route to the Synthesis of Novel Pyrazolo[1,5-a]pyrimidines and Evaluation of their Antimicrobial Activity as RNA Polymerase Inhibitors.
Abdallah AEM; Elgemeie GH
Med Chem; 2022; 18(9):926-948. PubMed ID: 35236270
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents.
Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S
Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020
[TBL] [Abstract][Full Text] [Related]
10. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
Madhava G; Ramana KV; Sudhana SM; Rao DS; Kumar KH; Lokanatha V; Rani AU; Raju CN
Med Chem; 2017; 13(5):484-497. PubMed ID: 28228088
[TBL] [Abstract][Full Text] [Related]
11. Designing, synthesis and characterization of 2-aminothiazole-4-carboxylate Schiff bases; antimicrobial evaluation against multidrug resistant strains and molecular docking.
Ejaz S; Nadeem H; Paracha RZ; Sarwar S; Ejaz S
BMC Chem; 2019 Dec; 13(1):115. PubMed ID: 31535091
[TBL] [Abstract][Full Text] [Related]
12. Bisthiourea Derivatives of Dipeptide Conjugated Benzo[d]isoxazole as a New Class of Therapeutics: Synthesis and Molecular Docking Studies.
Kumara HK; Suyoga Vardhan DM; Kumar JS; Gowda DC
Antiinflamm Antiallergy Agents Med Chem; 2017; 16(2):123-133. PubMed ID: 28820051
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel benzodioxole derivatives as COX inhibitors and cytotoxic agents.
Hawash M; Jaradat N; Hameedi S; Mousa A
BMC Chem; 2020 Dec; 14(1):54. PubMed ID: 32944715
[TBL] [Abstract][Full Text] [Related]
14. Biological Evaluation and Molecular Docking Studies of Novel 1,3,4-Oxadiazole Derivatives of 4,6-Dimethyl-2-sulfanylpyridine-3-carboxamide.
Świątek P; Glomb T; Dobosz A; Gębarowski T; Wojtkowiak K; Jezierska A; Panek JJ; Świątek M; Strzelecka M
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008977
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety.
Sağlık BN; Osmaniye D; Levent S; Çevik UA; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2021 Jan; 209():112918. PubMed ID: 33071054
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, Docking Studies, Enzyme Inhibitory and Antiplatelet Aggregation Activities of New 1,3-Diphenyl-3-(Phenylthio)Propan-1-One Derivatives as Selective COX-2 Inhibitors.
Bayanati M; Daraei B; Zarghi A
Anticancer Agents Med Chem; 2023; 23(2):192-200. PubMed ID: 35692149
[TBL] [Abstract][Full Text] [Related]
17. Indole hybridized diazenyl derivatives: synthesis, antimicrobial activity, cytotoxicity evaluation and docking studies.
Kaur H; Singh J; Narasimhan B
BMC Chem; 2019 Dec; 13(1):65. PubMed ID: 31384812
[TBL] [Abstract][Full Text] [Related]
18. Novel 1,3-diaryl pyrazole derivatives bearing methylsulfonyl moiety: Design, synthesis, molecular docking and dynamics, with dual activities as anti-inflammatory and anticancer agents through selectively targeting COX-2.
Shaker AMM; Shahin MI; AboulMagd AM; Abdel Aleem SA; Abdel-Rahman HM; Abou El Ella DA
Bioorg Chem; 2022 Dec; 129():106143. PubMed ID: 36191430
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of new 2-(4-(methylsulfonyl)phenyl)-
Movahed MA; Abbasi FK; Rajabi M; Abedi N; Naderi N; Daraei B; Zarghi A
Med Chem Res; 2023; 32(5):856-868. PubMed ID: 37056461
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities.
A A Fadaly W; A M M Elshaier Y; T M Nemr M; R A Abdellatif K
Bioorg Chem; 2023 May; 134():106428. PubMed ID: 36893546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
